David Lieberman

Statistics

Publications

Citations

1.5K

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Oregon Health & Science University

David Lieberman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, synthetic medicinal chemistry, and pharmacy.

Publications per year

1993–2019

Publications

Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn

Stuart J. Spechler, John G. Hunter, Karen Jones et al. · New England Journal of Medicine · 2019 · 261 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist

Robert D. Larsen, Anthony O. King, Cheng‐Yu Chen et al. · The Journal of Organic Chemistry · 1994 · 193 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database

Mary Kovalak, Jeremy Lake, Nora Mattek et al. · Gastrointestinal Endoscopy · 2006 · 193 citations

Medicine, Clinical Sciences, Internal Medicine +11

Syntheses of Indoles <i>via</i> a Palladium-Catalyzed Annulation between Iodoanilines and Ketones

Cheng‐yi Chen, David Lieberman, Robert D. Larsen et al. · The Journal of Organic Chemistry · 1997 · 165 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

Catalytic, Asymmetric, and Stereodivergent Synthesis of Non-Symmetric β,β-Diaryl-α-Amino Acids

Carmela Molinaro, Jeremy P. Scott, Michael Shevlin et al. · Journal of the American Chemical Society · 2014 · 105 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

1–5 of 19